Back to results
RecruitingPhase 2

Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)

NCT07283692

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, China

Contact

Wenjin Yin, M.D.

86(21)68385569yinwenjin@renji.com
View on ClinicalTrials.gov
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT) — TrialFind